{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T13:25:15Z","timestamp":1793280315789,"version":"4.5.0"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T00:00:00Z","timestamp":1762992000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T00:00:00Z","timestamp":1762992000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000038","name":"Natural Sciences and Engineering Research Council of Canada","doi-asserted-by":"publisher","award":["CCMOB-2021-00035"],"award-info":[{"award-number":["CCMOB-2021-00035"]}],"id":[{"id":"10.13039\/501100000038","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["REN- 181677"],"award-info":[{"award-number":["REN- 181677"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Public Health"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Opioid-related harms and deaths remain a persistent public health crisis across Ontario, Canada, with non-urban regions facing a disproportionate burden. However, discussions of opioid-related harms across Ontario\u2019s geographic regions have provided an oversimplified assessment, contrasting rural and urban regions which mask the unique challenges and true disparities faced by sparsely populated communities, which are commonly located in the Northern regions. Our study aims to provide a more in depth understanding of the opioid crisis in Ontario across different geographic classifications in accordance to population size, such as rural, urban, and sparsely populated regions, presenting data in both absolute numbers and crude rates with contextual grounding of regional characteristics. A number of different opioid-related indicators such as hospitalizations, overdose rates, opioid service provision and harm reduction supply distribution were analyzed across all 34 of Ontario\u2019s public health units (PHUs) to understand the differences in these indicators based on region across the province. The findings can inform the development of targeted interventions and improve service accessibility for those most affected by the overdose crisis in Ontario.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Publicly-available secondary data for each PHU was collected from several provincial and national data sources and analyzed between November 2024 and January 2025. Annual data from 2022 to 2023 on opioid-related harms, opioid agonist treatment (OAT) prescribers and engagement, and the distribution of harm reduction supplies, as well as annual data from 2024 on opioid-inclusive service provision, were collected. Using Statistics Canada\u2019s 2023 Health Region Peer Group Classification, the PHUS were grouped into four geographic classifications: sparsely populated, rural, urban\/rural mix, and urban. Crude average rates were calculated for all indicators. Statistical analysis was performed to assess significance of indicators between regions.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Sparsely populated PHUs were primarily located in Northern Ontario, while rural, urban\/rural mix, and urban PHUs were mainly concentrated in Southern Ontario. Urban PHUs have the highest number and lowest rate of opioid-related harms (e.g. 947 opioid-related deaths, representing a rate of 12.5 per 100,000 population), while sparsely populated PHUs reflect the opposite trend (e.g. 158 opioid-related deaths, representing a rate of 44.2 per 100,000 population). A similar pattern emerges for harm reduction services and naloxone distribution. The number of treatment services is highest in rural PHUs (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u2009237) and lowest in sparsely populated PHUs (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200983), despite having the highest rate. OAT prescribers, OAT engagement, and needle distribution follow a similar trend. Statistical significance was found between geographic regions for most indicators, except opioid-inclusive support services, harm reduction services, and naloxone distribution.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Sparsely populated and rural PHUs experience the highest burden of opioid-related harms, coupled with limitations in service accessibility, demonstrating a clear need for additional harm reduction services. Decision-makers may be misled into underestimating the crisis in non-urban areas as a result of oversimplified reporting, resulting in inadequate support for these regions. Addressing these disparities is key to reducing opioid-related mortality and ensuring equitable access to life-saving services across Ontario.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12889-025-25103-y","type":"journal-article","created":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T13:21:22Z","timestamp":1763040082000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Mapping the overdose crisis in Ontario: geographic disparities in opioid-related harms and services"],"prefix":"10.1186","volume":"25","author":[{"given":"Farihah","family":"Ali","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordan","family":"Mende-Gibson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sameer","family":"Imtiaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cayley","family":"Russell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shannon","family":"Chellew Paternostro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sami","family":"Aftab Abdul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikki","family":"Bozinoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David C.","family":"Marsh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pamela","family":"Leece","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00fcrgen","family":"Rehm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,13]]},"reference":[{"key":"25103_CR1","unstructured":"Government of Canada. Opioid- and Stimulant-related Harms in Canada. Available from: https:\/\/health-infobase.canada.ca\/substance-related-harms\/opioids-stimulants\/maps.html. Updated 2025\/03\/07."},{"key":"25103_CR2","unstructured":"The Opioid Crisis. A Municipal Perspective. Toronto, ON2024."},{"key":"25103_CR3","unstructured":"Quarterly Update from the Office of the Chief Coroner. Opioid toxicity deaths in Ontario. Ontario Drug Policy Research Network; 2024."},{"key":"25103_CR4","unstructured":"Chief Medical Officer of Health of Ontario to the Legislative Assembly of Ontario. Balancing act: an All-of-Society approach to substance use and harms. King\u2019s Printer for Ontario; 2024."},{"key":"25103_CR5","unstructured":"Ontario Agency for Health Protection and Promotion (Public Health Ontario). Technical notes: substance use and harms tool: King\u2019s Printer for Ontario; 2024. Available from: https:\/\/www.publichealthontario.ca\/-\/media\/Data-Files\/substance-use-harms-tool-technical-notes.pdf?sc_lang=en&rev=c1e12f6425714e2cb2f175f95aa46420&hash=229F71ED2030E2BC875EF40A311845CE."},{"key":"25103_CR6","doi-asserted-by":"publisher","first-page":"102607","DOI":"10.1016\/j.drugpo.2019.11.015","volume":"85","author":"N Thomas","year":"2020","unstructured":"Thomas N, Van de Ven K, Mulrooney KJ. The impact of rurality on opioid-related harms: A systematic review of qualitative research. Int J Drug Policy. 2020;85:102607.","journal-title":"Int J Drug Policy"},{"issue":"31","key":"25103_CR7","first-page":"59","volume":"7","author":"J Kopel","year":"2019","unstructured":"Kopel J. Opioid mortality in rural communities. Southwest Respir Crit Care Chron. 2019;7(31):59\u201362.","journal-title":"Southwest Respir Crit Care Chron"},{"key":"25103_CR8","unstructured":"Rural Health Information Hub. Rural Health Disparities. 2022. Available from: https:\/\/www.ruralhealthinfo.org\/topics\/rural-health-disparities. Updated Nov 12. 2024. Cited 2025 Feb."},{"issue":"36","key":"25103_CR9","doi-asserted-by":"publisher","first-page":"E1233","DOI":"10.1503\/cmaj.220892","volume":"194","author":"T Gomes","year":"2022","unstructured":"Gomes T, Kolla G, McCormack D, Sereda A, Kitchen S, Antoniou T. Clinical outcomes and health care costs among people entering a safer opioid supply program in Ontario. CMAJ. 2022;194(36):E1233\u201342.","journal-title":"CMAJ"},{"key":"25103_CR10","unstructured":"Thunder Bay District Health Unit. Superior Points Harm Reduction Program. Available from: https:\/\/www.tbdhu.com\/superiorpoints . Updated Jan 15, 2024."},{"issue":"9","key":"25103_CR11","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1001\/jamapsychiatry.2021.0976","volume":"78","author":"T Santo","year":"2021","unstructured":"Santo T, Clark B, Hickman M, Grebely J, Campbell G, Sordo L, et al. Association of opioid agonist treatment with all-cause mortality and specific causes of death among people with opioid dependence: a systematic review and meta-analysis. JAMA Psychiatry. 2021;78(9):979\u201393.","journal-title":"JAMA Psychiatry"},{"key":"25103_CR12","unstructured":"Public Health Ontario. Ontario Public Health System. 2020. Available from: https:\/\/www.publichealthontario.ca\/en\/About\/News\/2020\/Ontario-Public-Health-System?utm_source=chatgpt.com."},{"key":"25103_CR13","unstructured":"Ontario Government. Ontario Health Teams: King\u2019s Printer for Ontario. 2023. Available from: https:\/\/www.ontario.ca\/page\/ontario-health-teams. Updated Apr 11, 2025."},{"key":"25103_CR14","unstructured":"Thomson M, Sinha M, Hemm S, Pinault L. Insights on Canadian Society: Beyond urban and rural: Rethinking the social geography of Canada. 2025."},{"key":"25103_CR15","unstructured":"Gomes T, Murray R, Kolla G, Leece P, Bansal S, Besharah J, et al. Changing circumstances surrounding Opioid-Related deaths in Ontario during the COVID-19 pandemic. Ontario Drug Policy Research Network. 2021."},{"key":"25103_CR16","unstructured":"Rural Ontario Institute. Community Wellbeing Indicator Definitions. Available from: https:\/\/www.ruralontarioinstitute.ca\/wellbeing-definitions. Updated September 2024. Cited 2025 February."},{"issue":"1","key":"25103_CR17","doi-asserted-by":"publisher","DOI":"10.1186\/s13011-022-00463-5","volume":"17","author":"EM Pijl","year":"2022","unstructured":"Pijl EM, Alraja A, Duff E, Cooke C, Dash S, Nayak N, et al. Barriers and facilitators to opioid agonist therapy in rural and remote communities in Canada: an integrative review. Subst Abuse Treat Prev Policy. 2022;17(1):62.","journal-title":"Subst Abuse Treat Prev Policy"},{"key":"25103_CR18","unstructured":"Statistics Canada, Cencus, Profile. 2021 Cencus of Population. In: 98-316-X2021001 SCCn, editor. 2023."},{"key":"25103_CR19","unstructured":"Utah Department of Health and Human Services. Health Event Counts and Crude, Age-specific, and Age-adjusted Rates. Available from: https:\/\/ibis.utah.gov\/ibisph-view\/query\/Count_Rate.html."},{"key":"25103_CR20","unstructured":"Statistics Canada. Health Region Peer Groups \u2013 Working paper, 2023. 2024."},{"key":"25103_CR21","doi-asserted-by":"publisher","first-page":"E1280","DOI":"10.1503\/cmaj.241173","volume":"196","author":"I Yakovenko","year":"2024","unstructured":"Yakovenko I, Mukaneza Y, Germ\u00e9 K, Belliveau J, Fraleigh R, Bach P, et al. Management of opioid use disorder: 2024 update to the National clinical practice guideline. Can Med Assoc J. 2024;196:E1280\u201390.","journal-title":"Can Med Assoc J"},{"key":"25103_CR22","unstructured":"Public Health Ontario. Substance Use and Harms Tool. 2024. Available from: https:\/\/www.publichealthontario.ca\/en\/data-and-analysis\/substance-use\/substance-use-harms-tool."},{"key":"25103_CR23","unstructured":"Ontario Drug Policy Research Network. Ontario Opioid Indicator Tool [updated August 2024. Available from: https:\/\/odprn.ca\/ontario-opioid-indicator-tool\/."},{"key":"25103_CR24","unstructured":"Ontario Drug Policy Research Network. Ontario Opioid Indicator Tool Technical Appendix. 2024. Available from: https:\/\/odprn.ca\/wp-content\/uploads\/2024\/04\/Ontario-Opioid-Indicator-Tool-Technical-Appendix-April-2024.pdf."},{"key":"25103_CR25","unstructured":"ConnexOntario. Interactive Reports [updated 2025. Available from: https:\/\/connexontario.ca\/interactive-reports\/."},{"key":"25103_CR26","unstructured":"ConnexOntario. Database Inclusion Criteria. 2024. Available from: https:\/\/connexontario.ca\/wp-content\/uploads\/2024\/08\/2024-ConnexOntario-Database-Inclusion-Criteria.pdf."},{"key":"25103_CR27","unstructured":"Government of Canada. Health Canada\u2019s Substance Use and Addictions Program: Active Projects. Updated 2025. Available from: https:\/\/www.canada.ca\/en\/health-canada\/services\/substance-use\/canadian-drugs-substances-strategy\/funding\/substance-use-addictions-program\/active-projects.html."},{"key":"25103_CR28","unstructured":"Government of Canada. Supervised consumption sites: Status of applications. Updated 2025. Available from: https:\/\/www.canada.ca\/en\/health-canada\/services\/substance-use\/supervised-consumption-sites\/status-application.html."},{"key":"25103_CR29","unstructured":"Ministry of Health. Where to get a free naloxone kit 2017. Updated 2024. Available from: https:\/\/www.ontario.ca\/page\/where-get-free-naloxone-kit."},{"key":"25103_CR30","unstructured":"Association of Local Public Health Agencies. List of Health Units sorted by Municipality. Available from: https:\/\/cdn.ymaws.com\/www.alphaweb.org\/resource\/collection\/86D31666-E7EA-42F1-BDA1-A03ECA0B4E3D\/Health_Unit_By_Municipality.pdf."},{"key":"25103_CR31","unstructured":"Ontario Harm Reduction Distribution Program. Harm Reduction Progams. Available from: https:\/\/ohrdp.ca\/find-supplies\/."},{"key":"25103_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2020.102923","volume":"85","author":"A Whiteman","year":"2020","unstructured":"Whiteman A, Burnett J, Handanagic S, Wejnert C, Broz D, Group NS. Distance matters: the association of proximity to syringe services programs with sharing of syringes and injecting equipment-17 US cities, 2015. Int J Drug Policy. 2020;85:102923.","journal-title":"Int J Drug Policy"},{"issue":"2","key":"25103_CR33","doi-asserted-by":"publisher","first-page":"e79","DOI":"10.1016\/S2468-2667(23)00300-6","volume":"9","author":"I Rammohan","year":"2024","unstructured":"Rammohan I, Gaines T, Scheim A, Bayoumi A, Werb D. Overdose mortality incidence and supervised consumption services in Toronto, Canada: an ecological study and spatial analysis. Lancet Public Health. 2024;9(2):e79-87.","journal-title":"Lancet Public Health"},{"issue":"9775","key":"25103_CR34","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1016\/S0140-6736(10)62353-7","volume":"377","author":"BD Marshall","year":"2011","unstructured":"Marshall BD, Milloy MJ, Wood E, Montaner JS, Kerr T. Reduction in overdose mortality after the opening of North America\u2019s first medically supervised safer injecting facility: a retrospective population-based study. Lancet. 2011;377(9775):1429\u201337.","journal-title":"Lancet"},{"key":"25103_CR35","unstructured":"CATIE. Harm Reduction Satellite Sites Program. 2020. Available from: https:\/\/www.catie.ca\/programming-connection\/harm-reduction-satellite-sites-program."},{"key":"25103_CR36","doi-asserted-by":"crossref","unstructured":"Nunn A, Perri AM, Gordon H, Harding JP, Loo CJ, Tuinema J. Opioid-related deaths in Northern Ontario in the early COVID-19 pandemic period. Can J Public Health. 2024;116:1\u201312.","DOI":"10.17269\/s41997-024-00906-5"},{"issue":"11\u201312","key":"25103_CR37","doi-asserted-by":"publisher","first-page":"471","DOI":"10.24095\/hpcdp.44.11\/12.03","volume":"44","author":"D Viste","year":"2024","unstructured":"Viste D, Rioux W, Medwid M, Williams K, Tailfeathers E, Lee A, et al. Perceptions of overdose response hotlines and applications among rural and remote individuals who use drugs in Canada: a qualitative study. Health Promot Chronic Dis Prev Can. 2024;44(11\u201312):471.","journal-title":"Health Promot Chronic Dis Prev Can"},{"key":"25103_CR38","unstructured":"Wells C, Dolcine B, Frey N. Programs for the Treatment of Opioid Addiction: An Environmental Scan. Ottawa, ON; 2019."},{"key":"25103_CR39","doi-asserted-by":"crossref","unstructured":"Bray JH, Zaring-Hinkle B, Perrotte JK. Substance abuse in rural and remote areas. Handbook of rural, remote, and very remote mental health. 2020:1\u201323.","DOI":"10.1007\/978-981-10-5012-1_25-1"},{"key":"25103_CR40","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2020.108078","volume":"213","author":"N Kerman","year":"2020","unstructured":"Kerman N, Manoni-Millar S, Cormier L, Cahill T, Sylvestre J. It\u2019s not just injecting drugs: supervised consumption sites and the social determinants of health. Drug Alcohol Depend. 2020;213:108078.","journal-title":"Drug Alcohol Depend"},{"issue":"44","key":"25103_CR41","doi-asserted-by":"publisher","first-page":"E1350","DOI":"10.1503\/cmaj.171002","volume":"189","author":"KA Urbanoski","year":"2017","unstructured":"Urbanoski KA. Need for equity in treatment of substance use among Indigenous people in Canada. CMAJ. 2017;189(44):E1350-1.","journal-title":"CMAJ"},{"key":"25103_CR42","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2024.104631","volume":"134","author":"J Lavalley","year":"2024","unstructured":"Lavalley J, Steinhauer L, Bundy DB, Kerr T, McNeil R. They talk about it like it\u2019s an overdose crisis when in fact it\u2019s basically genocide: the experiences of Indigenous peoples who use illicit drugs in Vancouver\u2019s downtown Eastside neighbourhood. Int J Drug Policy. 2024;134:104631.","journal-title":"Int J Drug Policy"},{"issue":"6","key":"25103_CR43","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1097\/ADM.0000000000000156","volume":"9","author":"JK Eibl","year":"2015","unstructured":"Eibl JK, Gomes T, Martins D, Camacho X, Juurlink DN, Mamdani MM, et al. Evaluating the effectiveness of first-time methadone maintenance therapy across northern, rural, and urban regions of Ontario, Canada. J Addict Med. 2015;9(6):440\u20136.","journal-title":"J Addict Med"},{"issue":"1suppl","key":"25103_CR44","doi-asserted-by":"publisher","first-page":"S24","DOI":"10.1177\/0033354918793627","volume":"133","author":"B Saloner","year":"2018","unstructured":"Saloner B, McGinty EE, Beletsky L, Bluthenthal R, Beyrer C, Botticelli M, et al. A public health strategy for the opioid crisis. Public Health Rep. 2018;133(1suppl):S24\u201334.","journal-title":"Public Health Rep"},{"key":"25103_CR45","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2022.109473","volume":"236","author":"T Antoniou","year":"2022","unstructured":"Antoniou T, Men S, Tadrous M, Leece P, Munro C, Gomes T. Impact of a publicly funded pharmacy-dispensed naloxone program on fatal opioid overdose rates: a population-based study. Drug Alcohol Depend. 2022;236:109473.","journal-title":"Drug Alcohol Depend"},{"issue":"12","key":"25103_CR46","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1177\/07067437221089810","volume":"67","author":"SA Nairn","year":"2022","unstructured":"Nairn SA, Audet M, Stewart SH, Hawke LD, Isaacs JY, Henderson J, et al. Interventions to reduce opioid use in youth at-risk and in treatment for substance use disorders: a scoping review. Can J Psychiatry. 2022;67(12):881\u201398.","journal-title":"Can J Psychiatry"},{"key":"25103_CR47","unstructured":"Sprakes A, Rodericks-Schulwach A, Murray M, Kuhn S, Ambury S. Safer supply program evaluation: A response to drug poisonings in thunder Bay, Ontario. Lakehead University, Work SoS; 2024."},{"key":"25103_CR48","unstructured":"Ontario Protecting Communities and Supporting. Addiction recovery with new treatment hubs [press release]. King\u2019s Printer for Ontario; 2024."},{"key":"25103_CR49","unstructured":"An Act to enact two Acts and to amend various Acts with respect to public safety and the justice system, Legislative Assembly of Ontario, 1st Sess. (2024)."},{"key":"25103_CR50","doi-asserted-by":"publisher","DOI":"10.1016\/j.dialog.2024.100190","volume":"5","author":"AM Zuk","year":"2024","unstructured":"Zuk AM, Ahmed F, Charania NA, Sutherland C, Kataquapit G, Moriarity RJ, et al. An indigenous-led buprenorphine-naloxone treatment program to address opioid use in remote Northern Canada. Dialogues in Health. 2024;5:100190.","journal-title":"Dialogues in Health"},{"key":"25103_CR51","doi-asserted-by":"crossref","unstructured":"Morin KA, Tatangelo MR, Acharya S, Marsh DC. Cohort profile: the provincial opioid agonist treatment cohort in Ontario, Canada. Eur J Epidemiol. 2025;40(2):1\u20139.","DOI":"10.1007\/s10654-025-01202-3"},{"issue":"46","key":"25103_CR52","doi-asserted-by":"publisher","first-page":"E1568","DOI":"10.1503\/cmaj.220579","volume":"194","author":"G Matskiv","year":"2022","unstructured":"Matskiv G, Marshall T, Krieg O, Viste D, Ghosh SM. Virtual overdose monitoring services: a novel adjunctive harm reduction approach for addressing the overdose crisis. CMAJ. 2022;194(46):E1568-72.","journal-title":"CMAJ"},{"key":"25103_CR53","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12954-018-0273-3","volume":"16","author":"SC Mema","year":"2019","unstructured":"Mema SC, Frosst G, Bridgeman J, Drake H, Dolman C, Lappalainen L, et al. Mobile supervised consumption services in rural British columbia: lessons learned. Harm Reduct J. 2019;16:1\u20139.","journal-title":"Harm Reduct J"},{"key":"25103_CR54","doi-asserted-by":"publisher","DOI":"10.1016\/j.josat.2023.209272","volume":"159","author":"A Chatterjee","year":"2024","unstructured":"Chatterjee A, Baker T, Rudorf M, Walt G, Stotz C, Martin A, et al. Mobile treatment for opioid use disorder: implementation of community-based, same-day medication access interventions. J Subst Use Addict Treat. 2024;159:209272.","journal-title":"J Subst Use Addict Treat"},{"key":"25103_CR55","unstructured":"Public Health Ontario. Public Health Unit Mergers. 2025. Available from: https:\/\/www.publichealthontario.ca\/en\/About\/News\/2025\/01\/Public-Health-Unit-Mergers#:~:text=Effective%20January%201%2C%202025%2C%20the,Unit%20and%20Timiskaming%20Health%20Unit."},{"key":"25103_CR56","unstructured":"Public Health Ontario. Strengthening Public Health: Outcomes and Objectives to Support Voluntary Mergers. 2023."},{"key":"25103_CR57","unstructured":"Thunder Bay District Health Unit. Boards of Health not Proceeding with a Merger in Northwestern Ontario. Available from: https:\/\/www.tbdhu.com\/news\/boards-of-health-not-proceeding-merger-northwestern-ontario."},{"key":"25103_CR58","unstructured":"Ottawa Public Health. Ottawa\u2019s overdose overview. Available from: https:\/\/www.ottawapublichealth.ca\/en\/public-health-topics\/ottawa-s-overdose-overview.aspx."}],"container-title":["BMC Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-025-25103-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12889-025-25103-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-025-25103-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T13:21:43Z","timestamp":1763040103000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpublichealth.biomedcentral.com\/articles\/10.1186\/s12889-025-25103-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,13]]},"references-count":58,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["25103"],"URL":"https:\/\/doi.org\/10.1186\/s12889-025-25103-y","relation":{},"ISSN":["1471-2458"],"issn-type":[{"value":"1471-2458","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,13]]},"assertion":[{"value":"22 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"3935"}}